pharmatechoutlook
TECH OUTLOOK 4NOVEMBER - 2022COVER STORYThree C's to Enable Continuous Development and Manufacturing for Small Molecule Active Pharmaceutical IngredientIN MY OPINIONNick Thomson, Senior Director, Chemical Research & Development, Pfizer [NYSE:PFE]0812Notable LabsDr. Thomas A. Bock, CEO21Eurofins Viracor BiopharmaDoug Irving, Director of Marketing 18FEATURED COMPANIESTECH OUTLOOKTOP 10SOLUTIONS PROVIDERS - 2022DRUG DISCOVERYAND DEVELOPMENTCarterraCarterraCarterraACCELERATING THE DISCOVERY OF NOVEL THERAPEUTIC CANDIDATESJosh Eckman, CEO
< Page 3 | Page 5 >